Haemonetics (HAE) announced that it has entered into a definitive agreement to sell its whole blood assets to GVS, a manufacturer of filter ...
Haemonetics to sell whole blood assets to GVS for $67.1 million: Boston Wednesday, December 4, 2024, 10:00 Hrs [IST] Haemonetics Corporation, a global medical technology company f ...
Haemonetics (NYSE:HAE) announced today that it agreed to sell its whole blood assets to GVS S.p.A for $67.1 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback